Heiner Dreismann

Dr. Dreismann is a seasoned executive with more than 35 years of experience in the life sciences and healthcare industries and is regarded as a pioneer in the early adoption of the polymerase chain reaction technique, one of the most ubiquitous technologies in molecular biology and genetics research today.

He earned a master of science degree in biology and his doctor of philosophy degree in microbiology/molecular biology from Westfaelische Wilhelms University in Muenster, Germany. Heiner holds a post-doctoral fellowship at the French Center for Nuclear Research in Saclay, France, and then joined the biotechnology company, Roehm and Haas, in Darmstadt, Germany where he headed the genetic research and development effort to improve the yield of enzyme manufacturing fungal and bacterial strains. He then joined F. Hoffmann La Roche AG and held various national and international management positions including President and CEO of Roche Molecular Systems in Pleasanton, California (2000-2006).

Dr. Dreismann currently serves on the boards of several public and private life sciences and healthcare companies in the United States, Europe, and Israel.